Showing results (421-430 of 458) with videos related to
Sort By:
Pageof 46
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.Nature|June 19, 2009
Copy number variation at 1q21.1 associated with neuroblastomaSharon J Diskin, Cuiping Hou, Joseph T Glessner, et al.Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Germline pathogenic variants in 786 neuroblastoma patientsJung Kim, Zalman Vaksman, Laura E Egolf, et al.Cancer Cell|September 5, 2017
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and MetastasisShizhen Zhu, Xiaoling Zhang, Nina Weichert-Leahey, et al.Cancer Cell|October 22, 2019
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene SignaturesZulekha A Qadeer, David Valle-Garcia, Dan Hasson, et al.Nature Communications|August 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancersAlberto D Guerra, Smita Matkar, Christina Acholla, et al.Journal of the National Cancer Institute|September 9, 2023
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survivalJung Kim, Zalman Vaksman, Laura E Egolf, et al.Cancer Discovery|October 31, 2015
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyElena Sotillo, David M Barrett, Kathryn L Black, et al.Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.Nature|November 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancersDavid Steffin, Nisha Ghatwai, Antonino Montalbano, et al.Pageof 46